Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Elisavet Paplomata, Amelia Zelnak, Cesar A. Santa-Maria, Yuan Liu, Keerthi Gogineni, Xiaoxian Li, Carlos S. Moreno, Zhengjia Chen, Virginia Kaklamani, Ruth M. O'Regan

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience